JP-1366 Tablets

JP-1366 · Livzon Pharmaceutical Group Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JP-1366 Tablets, covering 2025-02-27 to 2025-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis [Phase 3]